关于监狱环境中的阿片类药物激动剂治疗的国家共识声明
Jocelyn Chan1,2,3, Jon Cook2,4, Michael Curtis1,3
1Burnet Institute, Melbourne, VIC.
The Medical journal of Australia
|March 2, 2025
概括
监狱中的阿片类激素治疗 (OAT) 需要改进. 这项研究提供了19条建议,以改善OAT的获取和连续性,旨在减少被监禁人员过量服用的死亡.
科学领域:
- 公共卫生 公共卫生
- 成 药物 药物 药物 药物
- 刑事司法 卫生 刑事司法 卫生
背景情况:
- 在监禁人群中,阿片类药物使用障碍很常见,导致高剂量过量风险.
- 片激动剂治疗 (OAT) 是有效的,但在监狱中的获取是不一致的.
- 澳大利亚监狱中OAT存在国家政策上的差距.
研究的目的:
- 制定基于证据的建议,以优化澳大利亚监狱中的OAT.
- 提高监禁人员OAT的质量,一致性和连续性.
- 为了解决释放后的主要死亡原因:过量服用.
主要方法:
- 一个经过修改的Delphi研究与国家多学科专家小组进行.
- 制定了19条建议,涵盖了五个核心领域.
- 建议于2024年7月完成.建议于2024年7月完成.
主要成果:
- 建议涉及OAT引入/延续,管理和社区过渡.
- 主要发现包括迅速的阿片类药物戒断管理和与社区OAT的联系.
- 强调组织支持,资金和监测至关重要.
结论:
- 实施这些建议将提高OAT的质量和一致性.
- 改善OAT供应对于改善健康结果和减少过量死亡至关重要.
- 这份共识声明提供了澳大利亚监狱OAT的最佳实践标准.
相关概念视频
Analgesia and Pain Management
422
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
422
Opioid Analgesics: Synthetic and Semisynthetic Opioids
204
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
204
Drug Abuse and Addiction: Pharmacological Phenomena
422
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
422
Opioid Receptors: Overview
422
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
422
Drug Dosage Regimen: Overview
3.4K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.4K
Drug Dependence
965
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
965


